{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:52Z","timestamp":1707524452885},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,12]]},"DOI":"10.7759\/cureus.21140","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T08:00:31Z","timestamp":1641974431000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Antibody Deficiencies With Pulmonary Complications: A Single-Center Experience"],"prefix":"10.7759","author":[{"given":"G\u00fczin","family":"\u00d6zden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pelin","family":"P\u0131nar Deniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pelin","family":"Duru Cetinkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS phenotypic classification for primary immunodeficiencies","volume":"38","author":"Bousfiha A","year":"2018","unstructured":"Bousfiha A, Jeddane L, Picard C, et al.. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2018, 38:129-43. 10.1007\/s10875-017-0465-8","journal-title":"J Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.10.002","article-title":"Inflammatory and autoimmune complications of common variable immune deficiency","volume":"5","author":"Knight AK","year":"2006","unstructured":"Knight AK, Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev. 2006, 5:156-9. 10.1016\/j.autrev.2005.10.002","journal-title":"Autoimmun Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye SG","year":"2020","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, et al.. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020, 40:24-64. 10.1007\/s10875-019-00737-x","journal-title":"J Clin Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2021.210234","article-title":"B cell subgroups as potential biomarkers in predominantly antibody deficiencies with complications","volume":"67","author":"Boral B","year":"2021","unstructured":"Boral B, Ozden G. B cell subgroups as potential biomarkers in predominantly antibody deficiencies with complications. Clin Lab. 2021, 67:10.7754\/Clin.Lab.2021.210234","journal-title":"Clin Lab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03292.x","article-title":"The European internet-based patient and research database for primary immunodeficiencies: results 2004-06","volume":"147","author":"Eades-Perner AM","year":"2007","unstructured":"Eades-Perner AM, Gathmann B, Knerr V, Guzman D, Veit D, Kindle G, Grimbacher B. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol. 2007, 147:306-12. 10.1111\/j.1365-2249.2006.03292.x","journal-title":"Clin Exp Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2020_556","article-title":"Primary immunodeficiencies: diseases of children and adults - a review","author":"Lewandowicz-Uszy\u0144ska A","year":"2021","unstructured":"Lewandowicz-Uszy\u0144ska A, Pasternak G, \u015awierkot J, Bogunia-Kubik K. Primary immunodeficiencies: diseases of children and adults - a review. Medical and Biomedical Updates. Springer Nature, Basingstoke, United Kingdom; 2021. 1289:37-54. 10.1007\/5584_2020_556"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9763-3","article-title":"The prevalences [correction] and patient characteristics of primary immunodeficiency diseases in Turkey\u2014two centers study","volume":"33","author":"Kilic SS","year":"2013","unstructured":"Kilic SS, Ozel M, Hafizoglu D, Karaca NE, Aksu G, Kutukculer N. The prevalences [correction] and patient characteristics of primary immunodeficiency diseases in Turkey\u2014two centers study. J Clin Immunol. 2013, 33:74-83. 10.1007\/s10875-012-9763-3","journal-title":"J Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2015.07.004","article-title":"Pulmonary manifestations of primary immunodeficiency disorders","volume":"35","author":"Nonas S","year":"2015","unstructured":"Nonas S. Pulmonary manifestations of primary immunodeficiency disorders. Immunol Allergy Clin North Am. 2015, 35:753-66. 10.1016\/j.iac.2015.07.004","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-014-0001-z","article-title":"Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry","volume":"34","author":"Aghamohammadi A","year":"2014","unstructured":"Aghamohammadi A, Mohammadinejad P, Abolhassani H, et al.. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol. 2014, 34:478-90. 10.1007\/s10875-014-0001-z","journal-title":"J Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0166","article-title":"Infectious and noninfectious pulmonary complications in patients with primary immunodeficiency disorders","volume":"27","author":"Yazdani R","year":"2017","unstructured":"Yazdani R, Abolhassani H, Asgardoon MH, Shaghaghi M, Modaresi M, Azizi G, Aghamohammadi A. Infectious and noninfectious pulmonary complications in patients with primary immunodeficiency disorders. J Investig Allergol Clin Immunol. 2017, 27:213-24. 10.18176\/jiaci.0166","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3527480","article-title":"Evaluation of clinical and immunological characteristics of children with common variable immunodeficiency","volume":"2018","author":"Alkan G","year":"2018","unstructured":"Alkan G, Keles S, Reisli \u0130. Evaluation of clinical and immunological characteristics of children with common variable immunodeficiency. Int J Pediatr. 2018, 2018:3527480. 10.1155\/2018\/3527480","journal-title":"Int J Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1412-108","article-title":"Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up","volume":"46","author":"\u00c7ali\u015fkaner AZ","year":"2016","unstructured":"\u00c7ali\u015fkaner AZ, Reisli \u0130, Arslan \u015e, U\u00e7ar R, Ataseven H, Sel\u00e7uk NY. Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up. Turk J Med Sci. 2016, 46:430-6. 10.3906\/sag-1412-108","journal-title":"Turk J Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0577-9","article-title":"Imaging of bronchial pathology in antibody deficiency: data from the European Chest CT Group","volume":"39","author":"Sch\u00fctz K","year":"2019","unstructured":"Sch\u00fctz K, Alecsandru D, Grimbacher B, et al.. Imaging of bronchial pathology in antibody deficiency: data from the European Chest CT Group. J Clin Immunol. 2019, 39:45-54. 10.1007\/s10875-018-0577-9","journal-title":"J Clin Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9511-0","article-title":"Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study","volume":"31","author":"Quinti I","year":"2011","unstructured":"Quinti I, Soresina A, Guerra A, et al.. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol. 2011, 31:315-22. 10.1007\/s10875-011-9511-0","journal-title":"J Clin Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2009.00963.x","article-title":"Detection of pulmonary complications in common variable immunodeficiency","volume":"21","author":"Touw CM","year":"2010","unstructured":"Touw CM, van de Ven AA, de Jong PA, Terheggen-Lagro S, Beek E, Sanders EA, van Montfrans JM. Detection of pulmonary complications in common variable immunodeficiency. Pediatr Allergy Immunol. 2010, 21:793-805. 10.1111\/j.1399-3038.2009.00963.x","journal-title":"Pediatr Allergy Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.14744\/TurkPediatriArs.2020.46656","article-title":"Evaluation of pulmonary findings in patients with humoral immunodeficiency","volume":"55","author":"Karal\u0131 Z","year":"2020","unstructured":"Karal\u0131 Z, Karal\u0131 Y, \u00c7eki\u00e7 \u015e, Yaz\u0131c\u0131 Z, Can\u0131tez Y, Sapan N, G\u00fcltekin S\u015eK. Evaluation of pulmonary findings in patients with humoral immunodeficiency. Turk Pediatri Ars. 2020, 55:174-83. 10.14744\/TurkPediatriArs.2020.46656","journal-title":"Turk Pediatri Ars"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: a\u00a0review of evidence","volume":"139","author":"Perez EE","year":"2017","unstructured":"Perez EE, Orange JS, Bonilla F, et al.. Update on the use of immunoglobulin in human disease: a\u00a0review of evidence. J Allergy Clin Immunol. 2017, 139:S1-S46. 10.1016\/j.jaci.2016.09.023","journal-title":"J Allergy Clin Immunol"},{"key":"ref18","unstructured":"Guidance for industry. safety, efficacy and pharmacokinetic studies to support marketing of IGIV (human) as replacement therapy for primary humoral immunodeficiency. (2021). Accessed: October 10, 2021: https:\/\/www.fda.gov\/media\/72157\/download."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-017-0404-8","article-title":"Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment","volume":"37","author":"Rider NL","year":"2017","unstructured":"Rider NL, Kutac C, Hajjar J, Scalchunes C, Seeborg FO, Boyle M, Orange JS. Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment. J Clin Immunol. 2017, 37:461-75. 10.1007\/s10875-017-0404-8","journal-title":"J Clin Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-015-0196-7","article-title":"Perceived health in patients with primary immune deficiency","volume":"35","author":"Seeborg FO","year":"2015","unstructured":"Seeborg FO, Seay R, Boyle M, Boyle J, Scalchunes C, Orange JS. Perceived health in patients with primary immune deficiency. J Clin Immunol. 2015, 35:638-50. 10.1007\/s10875-015-0196-7","journal-title":"J Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/82886-primary-antibody-deficiencies-with-pulmonary-complications-a-single-center-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:14Z","timestamp":1707507734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/82886-primary-antibody-deficiencies-with-pulmonary-complications-a-single-center-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.21140","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,12]]}}}